Image de couverture de livre

Clinical pharmacology in adolescent transgender medicine

Fuente: Wiley Open Access

Enregistré dans:

Détails bibliographiques
Auteurs principaux:	Lauren R. Cirrincione, Kai J. Huang, Gina M. Sequeira
Format:	Artículo Open Access
Publié:	Wiley 2024
Sujets:	British Journal of Clinical Pharmacology
Accès en ligne:	Acceder al recurso
Tags:	Ajouter un tag Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires

Assessment of clinical pharmacology and competence during medicine clerkships
par: Nicole C. Cheung, et autres
Publié: (2025)

Transgender people in clinical trials of drugs and biologics: An analysis of ClinicalTrials.gov from 2007 to 2023
par: Zachary Schonrock, et autres
Publié: (2024)

PrEP at the site of action in cisgender and transgender women: A pharmacology study of blood and rectal CD4 + lymphocytes
par: Elizabeth Hastie, et autres
Publié: (2026)

Clinical pharmacology in space for astronauts and earthlings
par: Jens Jordan, et autres
Publié: (2025)

Human hypoxia models in aerospace medicine: Potential applications for human pharmacological research
par: Titiaan E. Post, et autres
Publié: (2024)

Incorporating transgender and nonbinary participants in phase 1 clinical drug trials: Current knowledge gaps and considerations
par: Lauren E. Walker, et autres
Publié: (2024)

Cannabidiol in autism: Clinical pharmacology priorities for trial design
par: Gislei Frota Aragão, et autres
Publié: (2025)

The impact of curricular revision on student performance in pharmacology assessments
par: Erin R. Weeda, et autres
Publié: (2025)

Safe and supportive prescribing in transgender and non‐binary patients with cancer
par: Mariachiara D'Elia, et autres
Publié: (2024)

Clinical pharmacology considerations and drug–drug interactions with long‐acting cabotegravir and rilpivirine relevant to sub‐Saharan Africa
par: Adrian Steulet, et autres
Publié: (2024)

Clinical pharmacology and prescribing education: An updated medical school curriculum from the British Pharmacological Society
par: Dagan O. Lonsdale, et autres
Publié: (2026)

Appraising the visibility, relevance and impacts of clinical pharmacology
par: Serge Cremers, et autres
Publié: (2025)

Evaluation of artificial intelligence‐generated drug therapy communication skill competencies in medical education
par: Kannan Sridharan, et autres
Publié: (2024)

Student perspectives on AI‐supported formative assessment in pharmacology
par: Jon Andsnes Berg, et autres
Publié: (2025)

Using assessment in pharmacology to drive learning in the right direction
par: Roisin Kelly‐Laubscher, et autres
Publié: (2026)

Repeated intradermal lipopolysaccharide challenge responses in healthy volunteers: Implications for clinical pharmacology studies
par: Alexandra A. J. Sillé, et autres
Publié: (2026)

Bridging the gap between clinical pharmacology and rational drug prescribing 2.0: An up‐date after 30 years
par: Erik M. Donker, et autres
Publié: (2024)

Using non‐linear slide decks to administer individualized problem‐based learning assessments within pharmacology education
par: Wendy R. Francis, et autres
Publié: (2025)

Developing an international concept‐based curriculum for pharmacology education: The promise of core concepts and concept inventories
par: Clare Guilding, et autres
Publié: (2024)

The clinical toxicity of advanced therapy medicinal products
par: Fraser J. H. Henderson, et autres
Publié: (2025)

Formative feedback to improve pharmacology learning: Proposed principles and guidelines for effective practice
par: Thomas Anthony Angelo
Publié: (2026)

Assessing GPT‐4's accuracy in answering clinical pharmacological questions on pain therapy
par: Anna Stroop, et autres
Publié: (2025)

The clinical pharmacology and therapeutics course for graduating medical students at Dartmouth: Preparation for internship and residency
par: David W. Nierenberg, et autres
Publié: (2024)

Evidence to support integrating feedback best practice for computer‐based assessment in pharmacology education
par: Claire Y. Hepburn
Publié: (2025)

The interplay between molecular architecture, pharmacology, and suspected adverse drug reactions associated with nonsteroidal androgen antagonists in the United Kingdom
par: Simrit Dhillon, et autres
Publié: (2026)

Innovations in pharmacovigilance studies of medicines in older people
par: Lisa M. Kalisch Ellett, et autres
Publié: (2024)

Cross‐disciplinary mathematical modelling to benefit healthcare – could clinical pharmacology play an enabling role?
par: Tirhani Maluleke, et autres
Publié: (2024)

Precision medicine in paediatrics: Progress and priorities
par: Nicola Husain, et autres
Publié: (2026)

Section 19A in practice: Assessing the provision of overseas‐registered medicines to mitigate the impact of medicine shortages in Australia
par: Jack Janetzki, et autres
Publié: (2025)

From cradle to cane—(Dis)similarities between paediatric and geriatric clinical pharmacology: A commentary arising from the 2024 International Union of Basic and Clinical Pharmacology (IUPHAR) World Smart Medication Day
par: Karel Allegaert, et autres
Publié: (2025)

Therapeutic drug monitoring of dolutegravir in children and adolescents living with HIV: A retrospective study
par: E. Pilote, et autres
Publié: (2025)

Correction to “Evaluating the impact of general practice pharmacist‐led person‐centred medicines reviews on medicines appropriateness and patient‐reported outcome measures”
Publié: (2026)

A review on the role of extrapolation as basis for paediatric marketing authorization applications of medicines in the EU
par: Charlotte W. M. Simons, et autres
Publié: (2025)

Early clinical pharmacology evaluation of the novel anti‐inflammatory macrolide, glasmacinal (EP395): tolerability, pharmacokinetics and drug interactions
par: Dave Singh, et autres
Publié: (2026)

Morbimortality consequences of use and misuse of psychoactive medicines in Portugal
par: Ana Carmona Araújo, et autres
Publié: (2025)

Patient preferences and attitudes regarding the environmental impact of medicines: A discrete choice experiment
par: Milad Sadreghaemy, et autres
Publié: (2025)

Sustainable medicines development and use: Challenges and opportunities in the sustainable production of active pharmaceutical ingredients
par: Gary M. Noonan, et autres
Publié: (2024)

Cellular pharmacology of NRTI anabolites in PBMCS and platelets among persons with HIV receiving ABC/3TC‐ or TAF/FTC‐based art
Publié: (2024)

MCF classifier: Estimating, standardizing, and stratifying medicine carbon footprints, at scale
par: Haroon Taylor, et autres
Publié: (2024)

Advanced therapy medicinal products (ATMPs) – An analysis of the global regulatory status
par: Allan Cramer, et autres
Publié: (2026)